Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inorganic mineral encrustations on urinary catheters are crystalline deposits that form on the surface and within the lumen of indwelling urinary devices. These encrustations are primarily composed of struvite (magnesium ammonium phosphate) and hydroxyapatite (calcium phosphate) [1]. The formation process is typically initiated by infection with urease-producing bacteria, most notably Proteus mirabilis, which colonize the catheter and form a crystalline biofilm [2]. These bacteria produce the enzyme urease, which hydrolyzes urea into ammonia, leading to a significant increase in urinary pH; this alkalinity triggers the precipitation of calcium and magnesium phosphates from the urine [3]. Clinical consequences of these encrustations include catheter blockage, which can lead to painful urinary retention, reflux of infected urine to the kidneys, and the formation of bladder stones [4]. While not a traditional biological target like a protein or receptor, these mineral deposits are the focus of therapeutic interventions aimed at dissolution or prevention. Management often involves the use of acidic irrigation solutions, such as citric acid-based washes, to chemically dissolve the crystals, or the administration of urease inhibitors like acetohydroxamic acid to prevent the pH shift necessary for mineral precipitation [5]. [1] Stickler, D. J. (2008). Bacterial biofilms in catheter-associated urinary tract infection. Journal of Internal Medicine. [2] Broomfield, R. J., et al. (2009). Crystalline bacterial biofilm formation on urinary catheters by Proteus mirabilis. Journal of Medical Microbiology. [3] Nicolle, L. E. (2014). Catheter-associated urinary tract infections. Antimicrobial Resistance & Infection Control. [4] Getliffe, K. (1994). The characteristics and management of patients with recurrent bladder stone formation. Journal of Advanced Nursing. [5] Griffith, D. P., et al. (1978). Acetohydroxamic acid: Clinical studies of a urease inhibitor. Journal of Urology.
Chemical dissolution of mineral crystals through acidification of the local environment and inhibition of the bacterial urease enzyme to prevent pH elevation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inorganic mineral encrustations on urinary catheters.